Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study of NK510 Cell Therapy Combined With Monoclonal Antibody in the Treatment of Recurrent and Refractory Advanced Gastric Cancer

NCT06098898 is registered in ClinicalTrials.gov with Base Therapeutics (Shanghai) Co., Ltd. as lead sponsor.

NCT NCT06098898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06098898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study of NK510 Cell Therapy Combined With Monoclonal Antibody in the Treatment of Recurrent and Refractory Advanced Gastric Cancer
Lead sponsor
Base Therapeutics (Shanghai) Co., Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
November 1, 2023
Completion date
November 1, 2024
Enrollment
9 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer